Home > Press > Bio Nano Consulting appoints Lord Broers as Chairman of the Board
Abstract:
Appointment further enhances Bio Nano Consulting's capabilities in project managing partnerships between academia and the wider industry.
Bio Nano Consulting, specialists in bio and nanotechnology partnerships between the academic and industrial sectors, announces the appointment of Professor Lord Alec Broers as Chairman of the Board.
Professor Lord Broers brings extensive industry, academic and scientific expertise, having served at prominent University establishments, and as Chairman of the House of Lords Science and Technology Select Committee between 2004 and 2007. His remit at Bio Nano Consulting includes facilitating ongoing partnerships between academia and the wider life science and technology industries.
Educated at Melbourne University and the University of Cambridge, he subsequently worked in Research & Development at IBM laboratories in the USA for nineteen years - becoming an IBM Fellow and ultimately taking responsibility for the company's development of chip technologies.
Lord Broers returned to the UK in 1984 as Head of Electrical Engineering at Cambridge University and Fellow of Trinity College. He subsequently became Head of the Department of Engineering and Master of Churchill College.
More recently, Professor Lord Broers served as the Vice Chancellor of the University of Cambridge and was President of the Royal Academy of Engineering from 2001 to 2006. He was knighted in 1998 for services to education before being made a ‘life peer' in 2004.
Key responsibilities at Bio Nano Consulting include further strengthening the company's expanding revenue streams and building its growing reputation as the microsystems and nanotechnology consultancy of choice to the biomedical, healthcare and high-technology industries.
Commenting on the appointment, David Sarphie, Chief Executive Officer at Bio Nano Consulting, commented: "We are delighted to welcome Professor Lord Broers to our Board. His appointment brings further high-level expertise to the table. In particular, his wealth of experience in driving the strategy in businesses ranging from small start-ups through to large international conglomerates, including such eminent companies as IBM, coupled with his pedigree in the academic world, will be invaluable to Bio Nano, Consulting, adding additional weight to our skill sets, service offering and international standing."
####
About Bio Nano Consulting
Bio Nano Consulting is a commercially focussed consultancy, which addresses technical problems from industry utilising world class technology and expertise. We provide experienced project management and client facing business development to ensure projects are run on time and to budget. We have a rapidly expanding portfolio of clients from a variety of sectors; these include biotechnology, defence, electronics, pharmaceutical and med-tech.
For more information, please click here
Contacts:
t +44 (0)207 268 3032
f +44 (0)207 268 3184
Copyright © Bio Nano Consulting
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||